Tetra Bio-Pharma signs manufacturing agreement with Vitiprints for CAUMZ and HCC011

Tetra Bio-Pharma signed a definitive manufacturing agreement with Vitiprints LLC for commercial scale production of CAUMZ and HCC011 using Vitiprints' patented 2D printing technology. The agreement includes an exclusive license and milestone/royalty payments.

“Tetra Bio-Pharma today announced it has signed a definitive manufacturing agreement with Vitiprints LLC, for the commercial scale production of CAUMZ and HCC011.”globenewswire.com

• 1 source
• globenewswire.comTetra Bio-Pharma Enters into Manufacturing Agreement with Vitiprints LLC for CAUMZ™ and HCC011Tetra Bio-Pharma IncFeb 13, 2020

Summarized from public sources; check the original articles before acting on it.